Matos, Ignacio <br/><br/>
Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer.  [electronic resource] 

 -  Expert opinion on emerging drugs  Sep 2016 
 - 267-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7623 
<br/><br/><label>Standard No.: </label>10.1080/14728214.2016.1220535  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Colorectal Neoplasms--drug therapy<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Molecular Targeted Therapy<br/>Neoplasm Metastasis<br/>Protein Kinase Inhibitors--adverse effects<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Survival Rate